Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Expanso Capital is a French private equity and venture capital firm based in Bordeaux, serving as the dedicated investment subsidiary of Caisse d'Epargne Aquitaine Poitou-Charentes (CEAPC). Founded in 1999 and revitalized in 2014, the firm specializes in providing seed, early-stage, and growth capital to startups and small-to-medium enterprises (SMEs) within the Nouvelle-Aquitaine region. While maintaining a sector-agnostic approach, Expanso Capital has a significant track record in the life sciences, medtech, and digital health sectors, typically investing between €50,000 and €500,000 per transaction. The firm frequently collaborates with other regional institutional funds and business angel networks to support high-potential companies through their development phases. Notable healthcare-related investments in its portfolio include Hyprevention, a developer of innovative surgical solutions for hip fracture prevention.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Expanso Capital.